1-phenyl-2-decanoylamino-3-morpholino-1-propanol and Hyperlipidemias

1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with Hyperlipidemias in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amuzie, C; Avolio, A; Bedja, D; Berkowitz, D; Chatterjee, S; Kass, DA; Mishra, S; Renehan, M1

Other Studies

1 other study(ies) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and Hyperlipidemias

ArticleYear
Inhibition of glycosphingolipid synthesis ameliorates atherosclerosis and arterial stiffness in apolipoprotein E-/- mice and rabbits fed a high-fat and -cholesterol diet.
    Circulation, 2014, Jun-10, Volume: 129, Issue:23

    Topics: Animals; Antigens, CD; Aorta; Apolipoproteins E; Calcium; Cholesterol, Dietary; Coronary Artery Disease; Diet, High-Fat; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gene Expression Regulation; Glucosylceramides; Glycosphingolipids; Hyperlipidemias; Lactosylceramides; Lipoproteins, LDL; Male; Mice; Mice, Knockout; Models, Cardiovascular; Morpholines; Pulsatile Flow; Rabbits; Ultrasonography; Vascular Stiffness

2014